Hill-Rom Holdings, Inc. (HRC) Shares Sold by Citigroup Inc.

Citigroup Inc. cut its position in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) by 15.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,199 shares of the medical technology company’s stock after selling 2,437 shares during the period. Citigroup Inc.’s holdings in Hill-Rom were worth $1,169,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HRC. Oregon Public Employees Retirement Fund raised its position in shares of Hill-Rom by 8,755.0% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 2,308,056 shares of the medical technology company’s stock worth $26,000 after acquiring an additional 2,281,991 shares in the last quarter. Financial Gravity Companies Inc. bought a new position in shares of Hill-Rom in the 4th quarter worth $48,000. IMS Capital Management bought a new position in shares of Hill-Rom in the 3rd quarter worth $71,000. We Are One Seven LLC bought a new position in shares of Hill-Rom in the 4th quarter worth $93,000. Finally, Acadian Asset Management LLC bought a new position in shares of Hill-Rom in the 4th quarter worth $137,000. 84.22% of the stock is owned by institutional investors and hedge funds.

Shares of HRC stock opened at $104.24 on Friday. Hill-Rom Holdings, Inc. has a 1-year low of $81.82 and a 1-year high of $108.10. The company has a current ratio of 1.70, a quick ratio of 1.25 and a debt-to-equity ratio of 1.17. The firm has a market cap of $6.95 billion, a P/E ratio of 21.95, a price-to-earnings-growth ratio of 1.81 and a beta of 0.96.

Hill-Rom (NYSE:HRC) last announced its earnings results on Friday, January 25th. The medical technology company reported $1.02 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.98 by $0.04. Hill-Rom had a return on equity of 21.23% and a net margin of 7.21%. The firm had revenue of $683.50 million for the quarter, compared to the consensus estimate of $676.39 million. During the same period in the previous year, the business earned $0.92 EPS. The firm’s revenue for the quarter was up 2.1% on a year-over-year basis. On average, equities research analysts forecast that Hill-Rom Holdings, Inc. will post 5.04 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 29th. Investors of record on Friday, March 22nd will be paid a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 0.81%. This is an increase from Hill-Rom’s previous quarterly dividend of $0.20. The ex-dividend date is Thursday, March 21st. Hill-Rom’s payout ratio is 16.84%.

Separately, Zacks Investment Research lowered Hill-Rom from a “buy” rating to a “hold” rating and set a $111.00 price target for the company. in a research report on Wednesday, December 5th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the stock. Hill-Rom presently has an average rating of “Buy” and a consensus price target of $103.78.

TRADEMARK VIOLATION NOTICE: This story was first reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another domain, it was illegally copied and reposted in violation of US and international trademark and copyright legislation. The correct version of this story can be accessed at https://www.americanbankingnews.com/2019/03/17/hill-rom-holdings-inc-hrc-shares-sold-by-citigroup-inc.html.

Hill-Rom Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Recommended Story: Why are percentage gainers important?

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply